JNK‐IN‐8 treatment improves ARDS‐induced cognitive impairment by inhibiting JNK/NF‐κB‐mediated NLRP3 inflammasome

MLA

Yunchao Shi, et al. “JNK‐IN‐8 Treatment Improves ARDS‐induced Cognitive Impairment by Inhibiting JNK/NF‐κB‐mediated NLRP3 Inflammasome.” Brain and Behavior, vol. 13, no. 5, May 2023. EBSCOhost, https://doi.org/10.1002/brb3.2980.

APA

Yunchao Shi, Ying Fang, Peng Shen, He Liu, Longsheng Xu, Liyan Wang, & Maoxian Yang. (2023). JNK‐IN‐8 treatment improves ARDS‐induced cognitive impairment by inhibiting JNK/NF‐κB‐mediated NLRP3 inflammasome. Brain and Behavior, 13(5). https://doi.org/10.1002/brb3.2980

Chicago

Yunchao Shi, Ying Fang, Peng Shen, He Liu, Longsheng Xu, Liyan Wang, and Maoxian Yang. 2023. “JNK‐IN‐8 Treatment Improves ARDS‐induced Cognitive Impairment by Inhibiting JNK/NF‐κB‐mediated NLRP3 Inflammasome.” Brain and Behavior 13 (5). doi:10.1002/brb3.2980.